Anebulo Pharmaceuticals, Inc.
ANEB
$1.05
-$0.02-1.87%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.68% | -10.95% | -12.44% | -11.46% | 968.12% |
| Total Receivables | 479.59% | -86.61% | -- | -- | -87.45% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.69% | -34.66% | -50.49% | 44.14% | 17.07% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -11.97% | -11.93% | -13.36% | -10.31% | 684.48% |
|
|
|||||
| Total Current Assets | -11.97% | -11.93% | -13.36% | -10.31% | 684.48% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -10.56% | -9.50% | -8.68% | -55.01% | -11.81% |
| Total Assets | -11.95% | -11.89% | -13.30% | -11.57% | 541.89% |
|
|
|||||
| Total Accounts Payable | -8.66% | 170.96% | -47.57% | 33.83% | 26.74% |
| Total Accrued Expenses | 161.24% | 35.22% | 122.36% | -78.81% | 76.38% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 54.14% | 97.62% | -10.68% | -37.87% | 54.39% |
|
|
|||||
| Total Current Liabilities | 54.14% | 97.62% | -10.68% | -37.87% | 54.39% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 54.14% | 97.62% | -10.68% | -37.87% | 54.39% |
|
|
|||||
| Common Stock & APIC | 0.23% | 0.28% | 0.40% | 0.21% | 22.34% |
| Retained Earnings | -2.63% | -2.92% | -2.99% | -2.39% | -3.64% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -18.49% | -16.48% | -13.40% | -10.02% | 688.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.49% | -16.48% | -13.40% | -10.02% | 688.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.49% | -16.48% | -13.40% | -10.02% | 688.03% |
|
|
|||||